ABPI: UK aims high on life sciences, but investment lags behind pharma The government’s newly unveiled Life Sciences Sector Plan lays out an ambition to position the UK as a global life sciences leader by 2030. But the pharmaceutical industry has pushed back, warning that without major reforms to medicine funding and pricing, the strategy risks underdelivering. Published on Wednesday as part of government’s Industrial Strategy, the [...]
Major Smith & Nephew investors call for break-up of medical device maker healthcare Three of Smith & Nephew's biggest shareholders are reportedly urging the FTSE 100 firm to break up if it cannot improve performance.
Smith & Nephew slashes guidance as China slowdown continues Retail Hip and knee implant maker Smith & Nephew has cut its full-year guidance as it continues to grapple with a slowdown in China. It booked third quarter revenue of $1.4bn (£1.08bn), up four per cent year on year, but Chinese sales dragged as the region experienced “worse than expected headwinds” across the surgical businesses. The [...]
Could Smith & Nephew ditch the London Stock Exchange? July 4, 2024 Smith & Nephew is facing questions over whether it could ditch its London listing after activist investor Cevian Capital took a stake in the medical equipment manufacturer.
Smith & Nephew shares jump after activist investor Cevian takes stake July 4, 2024 The FTSE 100 firm's stock price rose as much as seven per cent in early trading, with Cevian taking a shareholding of just over five per cent.
FTSE 100 live: London markets flat despite inflation boost, miners rise February 27, 2024 Markets were also given a lift by the news that shop price inflation slowed to 2.5 per cent in February, the lowest level seen in two years.
Smith and Nephew lifts outlook as medical device revenue growth offsets China slowdown February 27, 2024 It wasn't all plain sailing for the medical tech giant however, with its operating profit for the year down to £335m, from £356m.
Sports medicine boosts Smith & Nephew results as chief financial officer steps down August 3, 2023 Medical device manufacturer Smith & Nephew has reported revenue and profit increases due to higher demand for sports medicines as the chief financial officer steps down. Strong performance in sports medicine, advanced wound management, and orthopaedics, which together make up 60 per cent of their business, has led to a 7.3 per cent rise in [...]
Churchill’s grandson and Serco chief named new chair of Smith & Nephew February 17, 2023 The grandson of Sir Winston Churchill and chief executive of Serco has been unveiled as the new chair of 167-year-old medical tech firm Smith & Nephew. Rupert Soames will assume the position at the London-listed company following the retirement of Roberto Quarta, the firm announced. He will take the reins in late September, after joining [...]
Smith & Nephew CEO to leave after salary spat, hitting share price October 21, 2019 Medical device manufacturer Smith & Nephew’s chief executive has announced his departure “by mutual agreement” with the board amid reports he was unhappy with his pay. Namal Nawana will be replaced by former Roche Diagnostics chief Roland Diggelman after just 18 months in the role, sending shares tumbling eight per cent to 1,683p. Read more: [...]